KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $792000.0.

  • Biolife Solutions' Non Operating Income rose 69548.87% to $792000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 16110.7%. This contributed to the annual value of -$4.3 million for FY2024, which is 18645.6% down from last year.
  • Per Biolife Solutions' latest filing, its Non Operating Income stood at $792000.0 for Q3 2025, which was up 69548.87% from $931000.0 recorded in Q2 2025.
  • Biolife Solutions' 5-year Non Operating Income high stood at $6.2 million for Q3 2021, and its period low was -$4.3 million during Q2 2024.
  • For the 5-year period, Biolife Solutions' Non Operating Income averaged around $608052.6, with its median value being $235000.0 (2023).
  • Its Non Operating Income has fluctuated over the past 5 years, first soared by 956666.67% in 2023, then plummeted by 18319.64% in 2024.
  • Over the past 5 years, Biolife Solutions' Non Operating Income (Quarter) stood at $142000.0 in 2021, then skyrocketed by 152.11% to $358000.0 in 2022, then plummeted by 81.01% to $68000.0 in 2023, then tumbled by 133.82% to -$23000.0 in 2024, then surged by 3543.48% to $792000.0 in 2025.
  • Its Non Operating Income stands at $792000.0 for Q3 2025, versus $931000.0 for Q2 2025 and $784000.0 for Q1 2025.